COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$165,000
+10.7%
43,483
+48.4%
0.00%
+33.3%
Q4 2019$149,000
+0.7%
29,301
-0.0%
0.00%0.0%
Q3 2019$148,000
-17.3%
29,315
+1.0%
0.00%0.0%
Q2 2019$179,000
+32.6%
29,026
+0.0%
0.00%
+50.0%
Q1 2019$135,000
+10.7%
29,018
+0.1%
0.00%0.0%
Q4 2018$122,000
-3.2%
28,992
+44.8%
0.00%0.0%
Q3 2018$126,000
+0.8%
20,019
+28.4%
0.00%0.0%
Q2 2018$125,00015,5940.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,583,925$8,007,0001.48%
Phocas Financial Corp. 1,022,708$5,169,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,776,490$8,980,0000.32%
FARALLON CAPITAL MANAGEMENT LLC 7,350,000$37,154,0000.28%
NEXPOINT ASSET MANAGEMENT, L.P. 716,880$3,624,0000.23%
J. Goldman & Co LP 499,698$2,526,0000.19%
PINNACLE ASSOCIATES LTD 1,257,098$6,355,0000.15%
CARILLON TOWER ADVISERS, INC. 3,948,024$19,957,0000.14%
EAGLE ASSET MANAGEMENT INC 4,504,094$22,768,0000.12%
Worth Venture Partners, LLC 32,956$167,0000.10%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders